EN DE

Englewood Lab Inc (950140) Fair Value & Analysis

Consumer Defensive · KR · Market cap 157B KRW

EL Englewood Lab Inc 950140 · KQ
Price8,360 KRW
Fair Value26,229 KRW
Upside+213.7%
Quality64/100
Watch Englewood Lab Inc for free, get notified when fair value or trend changes. Watch for free

Strengths

Trades 68% below our fair value of 26,229 KRW
Solidly profitable · 12.8% net margin
Low debt · generates free cash flow
Ranks above peers (8/9)

Risks

!Mixed Growth (revenue 5y +351.0 %/yr)
!Moderate moat 61/100
Mixed Growth (revenue 5y +351.0 %/yr)
Solidly profitable · 12.8% net margin
Low debt · generates free cash flow
2.52% dividend yield
Ranks above peers (8/9)
Moderate moat 61/100
Evidence: High Range 19,671 KRW – 37,949 KRW Share as image

Fair value as of: Aug 13, 2026

From 24 valuation models · updated 13 days ago

Share price +4.5% over the past month.

A solid business, trading 68% below our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Englewood Lab Inc and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card. Track it free

What matters now

  • The price is below even our cautious bear case (19,671 KRW). The market is more pessimistic than our downside scenario.
  • Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range (19,671 KRW to 37,949 KRW) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

26,200 KRW 3,870 KRW Fair Value 26,229 KRW Jan 2019 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 3,870 KRW – 26,200 KRW · fair‑value band 19,671 KRW – 37,949 KRW · the 8,360 KRW price screens below the 26,229 KRW fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Englewood Lab Inc (950140) currently trades at 8,360 KRW, while our model-based Fair Value estimate is 26,229 KRW, implying the stock looks roughly 213.7% undervalued today. The Quality Score stands at 64/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Englewood Lab Inc generated revenue of 224B KRW at a net margin of 12.8%. Revenue grew 16.9% year over year. It earns a return on equity of 18.1%. Net debt stands at 11.5B KRW. Fundamentals as of Aug 13, 2026

Our scenario range runs from 19,671 KRW (bear case) to 37,949 KRW (bull case); at 8,360 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 51% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -36% fair-value upside, at 214%, 950140 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 14,182 KRW 26,465 KRW 46,592 KRW 80
Residual Income 8,324 KRW 11,087 KRW 32,906 KRW 76
Rev-Margin DCF 18,077 KRW 32,314 KRW 62,007 KRW 74
All 24 models by family
DCF Models
FCF DCF 14,970 KRW 22,575 KRW 46,792 KRW 38
Owner Earnings 20,125 KRW 43,615 KRW 92,927 KRW 31
5Y Revenue Exit 16,465 KRW 28,484 KRW 53,741 KRW 39
5Y EBITDA Exit 21,129 KRW 37,915 KRW 70,903 KRW 41
5Y P/E Exit 20,197 KRW 44,852 KRW 78,768 KRW 38
10Y Revenue Exit 15,686 KRW 35,247 KRW 48,581 KRW 36
10Y EBITDA Exit 19,714 KRW 45,291 KRW 91,002 KRW 37
10Y P/E Exit 19,033 KRW 43,283 KRW 83,877 KRW 35
Earnings-Based
Graham-Dodd 8,493 KRW 59,229 KRW 83,119 KRW 54
Lynch FV 30,600 KRW 43,714 KRW 56,828 KRW 50
PEG = 1.0 30,600 KRW 43,714 KRW 56,828 KRW 46
EPV 17,832 KRW 20,519 KRW 22,870 KRW 59
Multiples
P/E Multiple 19,671 KRW 26,229 KRW 32,786 KRW 63
P/S Multiple 15,924 KRW 21,233 KRW 26,541 KRW 58
P/B Multiple 15,924 KRW 21,233 KRW 26,541 KRW 55
EV/EBIT 25,691 KRW 33,685 KRW 41,678 KRW 53
EV/EBITDA 22,617 KRW 29,585 KRW 36,554 KRW 54
EV/Revenue 15,459 KRW 21,351 KRW 27,244 KRW 43
Asset-Based
NCAV (Graham) 4,142 KRW 5,550 KRW 8,284 KRW 50
Growth DCF
Growth DCF 14,182 KRW 26,465 KRW 46,592 KRW 80
Rev-Margin DCF 18,077 KRW 32,314 KRW 62,007 KRW 74
Economic Profit
Residual Income 8,324 KRW 11,087 KRW 32,906 KRW 76
ROIC Compounder 23,821 KRW 37,623 KRW 49,124 KRW 72
Growth Earnings
Growth-Adj P/E 40,025 KRW 57,178 KRW 74,332 KRW 68

Widest divergence: Growth Earnings (57,178 KRW) versus Asset-Based (5,550 KRW). Highest evidence: Growth DCF (80).

Notify me when 950140 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/S ratio 0.82 TTM
Dividend yield 2.2%
Net margin 12.8% TTM
Return on equity 18.1% TTM
Return on assets 10.8% TTM
Operating margin 11.3% TTM
More key figures
Growth
Revenue (TTM) 224B KRW TTM
Revenue growth (YoY) +16.9% 3y avg +1,127%
EPS growth (YoY) +120%
Balance sheet & cash flow
Free cash flow 15.7B KRW FY2025
Net debt 11.5B KRW FY2022 · ≈ 0.7 yrs of FCF

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 64/100

Of which business quality 64 · Market factors (momentum, volatility) 23

Profitability 59
Margins and returns on capital today
Quality Growth 72
Are margins and returns improving?
Cashflow 42
Earnings quality: real cash, not paper profit
Fin. Strength 89
Balance sheet, leverage, solvency risk
Investment 31
Disciplined investing over empire-building
Low Volatility 61
Calm price path (market factor)
Momentum 9
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally.

Full company description

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, New Jersey. Englewood Lab, Inc. is a subsidiary of Cosmecca Korea Co., Ltd.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Englewood Lab Inc reported revenue of 217B KRW in FY2025 versus 141M KRW in FY2021, a compound +526.7%/yr. Reported net income was 24.8B KRW in FY2025, compounding +559.7%/yr from FY2021.

Growth Quality 86/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
217B KRW
Latest YoY
+162,174.8%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1,127.3%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+351.0%
Avg. revenue growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.2%
Value creation/yr We only publish this rate when it is defensible. Reason: rate outside our plausibility band
not computed
Revenue +526.7%/yr
FY21 141M KRW
FY22 117M KRW
FY23 158M KRW
FY24 134M KRW
FY25 217B KRW
Net income +559.7%/yr
FY21 13.1M KRW
FY22 5.6M KRW
FY23 15.9M KRW
FY24 14.4M KRW
FY25 24.8B KRW

Watch 950140: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Englewood Lab Inc Fair Value". https://www.fairvalue-calculator.com/stock/950140

Peer Group

Household & Personal Products · 251 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 64 · Above median
Return on equity (TTM) 18% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 13% · Top 25%
Operating margin (TTM) 11% · Above median
Revenue growth 17% · Top 25%
Dividend yield (TTM) 2.4% · Below median
Debt / equity 0.01× · Lower than median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 27
FUTURE85 · sector 4
PAST72 · sector 27
HEALTH99 · sector 98
DIVIDEND48 · sector 52

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Unilever PLC UNA €54.17 €40.47 -25%
Colgate-Palmolive Company CL $92.32 $55.28 -40%
500696 500696 ₹2,093 ₹641.55 -69%
Hindustan Unilever Limited HINDUNILVR ₹2,015 ₹789.46 -61%
Kenvue Inc KVUE $18.98 $10.97 -42%
Kimberly-Clark Corporation KMB $108.93 $79.71 -27%
Henkel AG HEN3 €77.52 €85.95 +11%
The Estée Lauder Companies Inc ESLA €86.54 €18.84 -78%
Church & Dwight Co CHD $102.53 $65.12 -36%
Beiersdorf Aktiengesellschaft, BEI €78.84 €68.36 -13%

Compare Englewood Lab Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Englewood Lab Inc (950140) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 26,229 KRW versus a price of 8,360 KRW, about +214% (undervalued).
What is the fair value of 950140?
Our model-based fair value for Englewood Lab Inc is 26,229 KRW (as of Aug 13, 2026), built from audited fundamentals. The current price: 8,360 KRW.
What is the quality score of 950140?
Englewood Lab Inc has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Englewood Lab Inc (950140)?
Englewood Lab Inc reported trailing-twelve-month revenue of about 224B KRW (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 950140?
The net profit margin of Englewood Lab Inc is about 12.8%, meaning it keeps roughly 12.8% of revenue as net income. Based on the latest reported figures.
Does Englewood Lab Inc pay a dividend?
Englewood Lab Inc currently shows a dividend yield of about 2.19% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free · no account needed

Watch Englewood Lab Inc in the live analysis

One click puts Englewood Lab Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.